DIA Biosimilars 2013

Harvard Medical School

Researchers use RNA technology to block inflammation

Tuesday, October 11, 2011 01:26 PM

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication in Nature Biotechnology, the investigators describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage.

More... »

Cenduit: Now with Patient Reminders

Enzon to cut half of its workforce in 2012

Friday, September 23, 2011 01:14 PM

Enzon Pharmaceuticals, a biotechnology company, said it will cut almost half its workforce in June 2012 to reduce annual operating costs by about $6 million, according to Bloomberg.

More... »

CRF Health – eCOA Forum

Harvard disciplines three psychiatrists under Sunshine Act

Wednesday, July 6, 2011 09:59 AM

Harvard Medical School and Massachusetts General Hospital have disciplined three faculty members in a conflict-of-interest case that became a prime exhibit in the debate over the federal Physician Payments Sunshine Act of 2010, according to the NPR Health Blog.

More... »

Dr. Ashley I. Bush joins Adeona's scientific advisory board

Friday, April 1, 2011 11:16 AM

ANN ARBOR, Mich.-based Adeona Pharmaceuticals, a developer of medicines for serious central nervous system diseases, announced that Ashley I. Bush, M.D., Ph.D., has joined the company's scientific advisory board.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.